Financial incentives for generic drugs: case study on a reimbursement program
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Einstein (São Paulo) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200154 |
Resumo: | ABSTRACT Objective: To discuss the use of financial incentives in choice of medication and to assess the economic results concerning the use of financial incentives to promote the use of genetic medication in lieu of reference drugs in a company with a reimbursement program. Methods: A case study was carried out in a large supermarket. The data was obtained in the company responsible for managing medication. The study reached 83,625 users between August 2005 and July 2007. The data was submitted to regressions in order to analyze trends and hypothesis tests to assess differences in medication consumption. The results were compared with general data regarding medication consumption of five other organizations and also with data about the national consumption of generic medication in Brazil. Results: The use of financial incentives to replace brand medications for generics, in the company studied, increased the consumption of generic drugs without reducing the company expenses with the reimbursement programs. Conclusions: This study show the occurrence of unplanned results (increase in the consumption of medications) and the positive consequences of the reimbursement program concerning access to medication. |
id |
IIEPAE-1_5470203239dbc348fdcbde0ba2430087 |
---|---|
oai_identifier_str |
oai:scielo:S1679-45082010000200154 |
network_acronym_str |
IIEPAE-1 |
network_name_str |
Einstein (São Paulo) |
repository_id_str |
|
spelling |
Financial incentives for generic drugs: case study on a reimbursement programReference drugsHealth managementDrugs, generic/supply & distributionReimbursement, incentive/economicsABSTRACT Objective: To discuss the use of financial incentives in choice of medication and to assess the economic results concerning the use of financial incentives to promote the use of genetic medication in lieu of reference drugs in a company with a reimbursement program. Methods: A case study was carried out in a large supermarket. The data was obtained in the company responsible for managing medication. The study reached 83,625 users between August 2005 and July 2007. The data was submitted to regressions in order to analyze trends and hypothesis tests to assess differences in medication consumption. The results were compared with general data regarding medication consumption of five other organizations and also with data about the national consumption of generic medication in Brazil. Results: The use of financial incentives to replace brand medications for generics, in the company studied, increased the consumption of generic drugs without reducing the company expenses with the reimbursement programs. Conclusions: This study show the occurrence of unplanned results (increase in the consumption of medications) and the positive consequences of the reimbursement program concerning access to medication.Instituto Israelita de Ensino e Pesquisa Albert Einstein2010-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200154einstein (São Paulo) v.8 n.2 2010reponame:Einstein (São Paulo)instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)instacron:IIEPAE10.1590/s1679-45082010ao1478info:eu-repo/semantics/openAccessInocencio,MarcosAmorim,Maria Cristina SanchesGuevara,Arnoldo Jose de HoyosVivo,Bruna deeng2017-03-14T00:00:00Zoai:scielo:S1679-45082010000200154Revistahttps://journal.einstein.br/pt-br/ONGhttps://old.scielo.br/oai/scielo-oai.php||revista@einstein.br2317-63851679-4508opendoar:2017-03-14T00:00Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)false |
dc.title.none.fl_str_mv |
Financial incentives for generic drugs: case study on a reimbursement program |
title |
Financial incentives for generic drugs: case study on a reimbursement program |
spellingShingle |
Financial incentives for generic drugs: case study on a reimbursement program Inocencio,Marcos Reference drugs Health management Drugs, generic/supply & distribution Reimbursement, incentive/economics |
title_short |
Financial incentives for generic drugs: case study on a reimbursement program |
title_full |
Financial incentives for generic drugs: case study on a reimbursement program |
title_fullStr |
Financial incentives for generic drugs: case study on a reimbursement program |
title_full_unstemmed |
Financial incentives for generic drugs: case study on a reimbursement program |
title_sort |
Financial incentives for generic drugs: case study on a reimbursement program |
author |
Inocencio,Marcos |
author_facet |
Inocencio,Marcos Amorim,Maria Cristina Sanches Guevara,Arnoldo Jose de Hoyos Vivo,Bruna de |
author_role |
author |
author2 |
Amorim,Maria Cristina Sanches Guevara,Arnoldo Jose de Hoyos Vivo,Bruna de |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Inocencio,Marcos Amorim,Maria Cristina Sanches Guevara,Arnoldo Jose de Hoyos Vivo,Bruna de |
dc.subject.por.fl_str_mv |
Reference drugs Health management Drugs, generic/supply & distribution Reimbursement, incentive/economics |
topic |
Reference drugs Health management Drugs, generic/supply & distribution Reimbursement, incentive/economics |
description |
ABSTRACT Objective: To discuss the use of financial incentives in choice of medication and to assess the economic results concerning the use of financial incentives to promote the use of genetic medication in lieu of reference drugs in a company with a reimbursement program. Methods: A case study was carried out in a large supermarket. The data was obtained in the company responsible for managing medication. The study reached 83,625 users between August 2005 and July 2007. The data was submitted to regressions in order to analyze trends and hypothesis tests to assess differences in medication consumption. The results were compared with general data regarding medication consumption of five other organizations and also with data about the national consumption of generic medication in Brazil. Results: The use of financial incentives to replace brand medications for generics, in the company studied, increased the consumption of generic drugs without reducing the company expenses with the reimbursement programs. Conclusions: This study show the occurrence of unplanned results (increase in the consumption of medications) and the positive consequences of the reimbursement program concerning access to medication. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200154 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082010000200154 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/s1679-45082010ao1478 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Instituto Israelita de Ensino e Pesquisa Albert Einstein |
publisher.none.fl_str_mv |
Instituto Israelita de Ensino e Pesquisa Albert Einstein |
dc.source.none.fl_str_mv |
einstein (São Paulo) v.8 n.2 2010 reponame:Einstein (São Paulo) instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) instacron:IIEPAE |
instname_str |
Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) |
instacron_str |
IIEPAE |
institution |
IIEPAE |
reponame_str |
Einstein (São Paulo) |
collection |
Einstein (São Paulo) |
repository.name.fl_str_mv |
Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE) |
repository.mail.fl_str_mv |
||revista@einstein.br |
_version_ |
1752129905797103616 |